Chemomab Therapeutics Reports Q4 EPS $(0.02) Vs. $(0.01) YoY

Chemomab Therapeutics Reports Q4 EPS $(0.02) Vs. $(0.01) YoY
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNews
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!